Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Sundry Debtors

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Sundry Debtors ₹848 Cr₹576 Cr₹388 Cr₹331 Cr₹531 Cr

What is the latest Sundry Debtors ratio of MANKIND PHARMA ?

The latest Sundry Debtors ratio of MANKIND PHARMA is ₹848 Cr based on Mar2024 Consolidated results.
Year Sundry Debtors
Mar2024₹848 Cr
Mar2023₹576 Cr
Mar2022₹388 Cr
Mar2021₹331 Cr
Mar2020₹531 Cr

How is Sundry Debtors of MANKIND PHARMA Trending?

Years Sundry Debtors % Change
Mar2024 ₹848 Cr
47.16
Mar2023 ₹576 Cr
48.50
Mar2022 ₹388 Cr
17.41
Mar2021 ₹331 Cr
-37.75
Mar2020 ₹531 Cr -

Compare Sundry Debtors of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹101,363.4 Cr 2.4% 7.1% 3.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,155.0 Cr -3.9% 3% 7.9% Stock Analytics
DIVIS LABORATORIES ₹147,295.0 Cr -5% -1.1% 71.6% Stock Analytics
CIPLA ₹116,664.0 Cr -4.4% 0.2% -1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,678.0 Cr -1.6% 6.5% 26.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,162.6 Cr -2.4% 2.4% -5.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.4%

7.1%

3.9%

SENSEX

-2.5%

1.9%

4.9%


You may also like the below Video Courses